AAREYDRUGS

Aarey Drugs & Pharmaceuticals Share PriceAarey Drugs & Pharmaceuticals

₹46.55
As on 03 December, 2023 | 22:15 BSE: 524412 NSE: AAREYDRUGSISIN: INE198H01019

Aarey Drugs & Pharmaceuticals Performance

Day Range

  • Low 45.65
  • High 46.50
₹ 46.55

52 Week Range

  • Low 22.00
  • High 55.90
₹ 46.55
  • Open Price0.00
  • Previous Close46.55
  • Volume2552

Start SIP in Aarey Drugs & Pharmaceuticals

Start SIP

Aarey Drugs & Pharmaceuticals Share Price

  • Over 1 Month 11.1%
  • Over 3 Month -3.02%
  • Over 6 Month 55.95%
  • Over 1 Year 24.47%

Aarey Drugs & Pharmaceuticals Key Statistics

P/E Ratio 49.9
PEG Ratio -1
Market Cap Cr 118
Price to Book Ratio 1
EPS 1.5
Dividend 0
Relative Strength Index 44.91
Money Flow Index 78.72
MACD Signal 0.65
Average True Range 1.36

Aarey Drugs & Pharmaceuticals Investment Rating

  • Master Rating:
  • Aarey Drugs & Pharms. has an operating revenue of Rs. 329.44 Cr. on a trailing 12-month basis. An annual revenue de-growth of -15% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 4%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 24% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. It is currently FORMING a base in its weekly chart and is trading around 10% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 28 which is a POOR score indicating inconsistency in earnings, a RS Rating of 58 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 72 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Aarey Drugs & Pharmaceuticals Financials
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 58511586276117120
Operating Expenses Qtr Cr 56501606172118118
Operating Profit Qtr Cr 21-224-12
Depreciation Qtr Cr 0001000
Interest Qtr Cr 1111111
Tax Qtr Cr 0020003
Net Profit Qtr Cr 110031-1
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 422495
Operating Expenses Annual Cr 411481
Operating Profit Annual in Cr 811
Depreciation Cr 22
Interest Annual Cr 32
Tax Annual Cr 23
Net Profit Annual Cr 47
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -1-4
Cash from Investing Activity Annual Cr 0-2
Cash from Financing Annual Activity Cr 16
Net Cash Flow Annual Cr 10
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 117114
Fixed Assets Annual Cr 1414
Total Non Current Assets Annual Cr 2119
Total Current Assets Annual Cr 271226
Total Assets Annual Cr 291245
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 4645
ROE Annual % 36
ROCE Annual % 710
Total Debt to Total Equity Annual --
EBDIT Annual Margin % 23
IndicatorSep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual --
EBDIT Annual Margin %

Aarey Drugs & Pharmaceuticals Technicals

EMA & SMA

Current Price
₹46.55
0 (0%)
pointer
  • Bullish Moving Average
  • ___
  • 8
  • Bearish Moving Average
  • ___
  • 8
  • 20 Day
  • ₹47.06
  • 50 Day
  • ₹46.15
  • 100 Day
  • ₹43.82
  • 200 Day
  • ₹40.63
  • 20 Day
  • ₹47.66
  • 50 Day
  • ₹46.14
  • 100 Day
  • ₹44.46
  • 200 Day
  • ₹36.80

Aarey Drugs & Pharmaceuticals Resistance and Support

PIVOT
₹45.95
Resistance
First Resistance 46.25
Second Resistance 46.80
Third Resistance 47.10
RSI 44.91
MFI 78.72
MACD Single Line 0.65
MACD 0.40
Support
First Resistance 45.40
Second Resistance 45.10
Third Resistance 44.55

Aarey Drugs & Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 3,399 339,900 100
Week 6,566 656,600 100
1 Month 36,715 3,671,471 100
6 Month 113,035 7,678,475 67.93

Aarey Drugs & Pharmaceuticals Result Highlights

Aarey Drugs & Pharmaceuticals Synopsis

NSE-Medical-Diversified

Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 418.96 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2023. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.
Market Cap 116
Sales 329
Shares in Float 1.27
No of funds 3
Yield 0.44
Book Value 0.99
U/D Vol ratio 1.1
LTDebt / Equity 4
Alpha 0.11
Beta 0.87

Aarey Drugs & Pharmaceuticals

Owner NameSep-23Jun-23Mar-23Dec-22
Promoters 50.04%50.04%50.04%50.03%
Foreign Portfolio Investors 3.94%3.92%3.92%3.92%
Individual Investors 40.61%42.24%42.24%42.41%
Others 5.41%3.8%3.8%3.64%

Aarey Drugs & Pharmaceuticals Management

Name Designation
Mr. Mihir R Ghatalia Chairman & Managing Director
Mr. Nimit Rajesh Ghatalia Executive Director
Ms. Archana Pramod Wani Woman Director
Mr. Lalit Radhakrishna Tulsiani Independent Director
Mr. Anil Mandal Independent Director
Mr. Chetan K Mehta Independent Director

Aarey Drugs & Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Aarey Drugs & Pharmaceuticals Corporate Action

Date Purpose Remarks
2023-11-11 Quarterly Results
2023-08-14 Quarterly Results
2023-08-10 Preferential issue & Issue of Warrants
2023-07-31 Preferential issue of shares
2023-06-21 Preferential issue of shares

Aarey Drugs & Pharmaceuticals FAQs

What is Share Price of Aarey Drugs & Pharmaceuticals ?

Aarey Drugs & Pharmaceuticals share price is ₹46 As on 03 December, 2023 | 22:01

What is the Market Cap of Aarey Drugs & Pharmaceuticals ?

The Market Cap of Aarey Drugs & Pharmaceuticals is ₹118.2 Cr As on 03 December, 2023 | 22:01

What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?

The P/E ratio of Aarey Drugs & Pharmaceuticals is 49.9 As on 03 December, 2023 | 22:01

What is the PB ratio of Aarey Drugs & Pharmaceuticals ?

The PB ratio of Aarey Drugs & Pharmaceuticals is 1 As on 03 December, 2023 | 22:01

Q2FY23